ARCHIVES

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Eight Firms Join AACR As Sustaining Members

April 25, 1997

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain

April 15, 1988

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012